Search alternatives:
less decrease » mean decrease (Expand Search), levels decreased (Expand Search), largest decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
less decrease » mean decrease (Expand Search), levels decreased (Expand Search), largest decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
601
Study-related adverse events.
Published 2025“…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
602
Study flow chart.
Published 2025“…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
603
Study CONSORT diagram.
Published 2025“…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
604
This is the raw data used for this study.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
605
Pre-operative versus post-operative symptoms.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
606
Patient Demographics.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
607
Diagnostic Criteria for Human Disharmony Loop.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
608
Correlation between age and telomere age (TMA).
Published 2025“…<div><p>Telomere length is a known indicator of biological aging, typically decreasing with age. Biological age is a benchmark for assessing an individual’s health and aging. …”
-
609
Effects of CGA on renal biochemical markers.
Published 2025“…The results show that the level of serum creatinine (Scr), blood urea nitrogen (BUN), and urinary protein excretion in diabetic rats were significantly decreased after CGA intervention. CGA administration can active the Nrf2 pathway and inhibit NLRP3 inflammasome activation. …”
-
610
S1 Raw data -
Published 2024“…Compared to pre-match values, hamstring strength was significantly decreased after 15 and 30 minutes of simulated soccer match for the non-dominant and dominant leg, respectively. …”
-
611
S2 Raw data -
Published 2024“…Compared to pre-match values, hamstring strength was significantly decreased after 15 and 30 minutes of simulated soccer match for the non-dominant and dominant leg, respectively. …”
-
612
Summary of HSS and LSI during the LIST.
Published 2024“…Compared to pre-match values, hamstring strength was significantly decreased after 15 and 30 minutes of simulated soccer match for the non-dominant and dominant leg, respectively. …”
-
613
All data points from Fig 2.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
-
614
All data points from Fig 5.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
-
615
All data points from Fig 8.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
-
616
All data points from Fig 3.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
-
617
All data points from Fig 1.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
-
618
All data points from Fig 4.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
-
619
All data points from Fig 9.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
-
620
All data points from Fig 7.
Published 2025“…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”